Influenza Medications Market Size

Influenza Medications Market Size

Influenza Medications Market size in 2023 was valued at USD 942.6 million and is anticipated to showcase growth at 2.9% to reach USD 1.2 billion by 2032. One of the major factors contributing to the growth of this market is the increasing prevalence of influenza.

To get key market trends

  Download Free Sample

For instance, Centers of Disease Control and Prevention (CDC) estimated that during the 2022-2023 season, influenza was associated with 31 million illnesses, 14 million medical visits, 360,000 hospitalizations, and 21,000 deaths in the U.S. Such high number of cases of influenza, necessitate the need for effective treatments, thereby aiding in market growth. In addition, pharmaceutical companies are investing in the development of novel antiviral agents with unique mechanisms of action against influenza viruses. Furthermore, the advanced influenza diagnostic tests including the development of rapid influenza diagnostic tests facilitates early diagnosis of disease and treatment, further fostering the market growth.
 

Influenza medication refers to pharmaceutical drugs and treatments specifically designed to prevent, manage, or alleviate the symptoms of influenza, commonly known as the flu. These medications include antiviral drugs, antihistamines, and others. These medications are prescribed or recommended by healthcare professionals and are available in various forms, including oral medications, inhalation medications, and injectable medications.